{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Acitretin不良反应风险",
            "expectation": "若条件成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Methotrexate不良反应风险",
            "expectation": "若条件成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tildrakizumab",
          "type": "Drug",
          "label": "Tildrakizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_interleukin_17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_tg",
          "type": "Target",
          "label": "Target for Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pw",
          "type": "Pathway",
          "label": "Pathway for psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_acitretin",
          "type": "Target",
          "label": "Acitretin Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_acitretin",
          "type": "Pathway",
          "label": "Acitretin Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_acitretin",
          "type": "Phenotype",
          "label": "Adverse Effects of Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "Methotrexate Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_methotrexate",
          "type": "Pathway",
          "label": "Methotrexate Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_methotrexate",
          "type": "Phenotype",
          "label": "Adverse Effects of Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cyclosporine",
          "type": "Target",
          "label": "Cyclosporine Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_cyclosporine",
          "type": "Pathway",
          "label": "Cyclosporine Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_cyclosporine",
          "type": "Phenotype",
          "label": "Adverse Effects of Cyclosporine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_infliximab",
          "type": "Target",
          "label": "Infliximab Off-target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_infliximab",
          "type": "Pathway",
          "label": "Infliximab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_infliximab",
          "type": "Phenotype",
          "label": "Adverse Effects of Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Acitretin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Secukinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Tildrakizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Apremilast",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_acitretin",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "常用药物显示效果"
        },
        {
          "source": "n_tg",
          "target": "n_pw",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通路层面关联"
        },
        {
          "source": "n_pw",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路通向已明确的病症"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "有效的免疫抑制药物"
        },
        {
          "source": "drug_cyclosporine",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "常用于严重病例"
        },
        {
          "source": "drug_infliximab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "抗体疗法对皮肤病有效"
        },
        {
          "source": "drug_etanercept",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "肿瘤坏死因子抑制剂的有效性"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有效的生物药物"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "靶向IL-17，适合千疮"
        },
        {
          "source": "drug_tildrakizumab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "IL-23抑制剂，显示效果"
        },
        {
          "source": "drug_ustekinumab",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "靶向免疫耐受，应用于多种类型"
        },
        {
          "source": "drug_topical_corticosteroids",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "局部治疗常见选择"
        },
        {
          "source": "drug_apremilast",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "小分子药物，可能适合"
        },
        {
          "source": "drug_interleukin_17_inhibitors",
          "target": "n_tg",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "干扰IL-17信号，有前景"
        },
        {
          "source": "drug_acitretin",
          "target": "n_ot_acitretin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致不良反应"
        },
        {
          "source": "n_ot_acitretin",
          "target": "n_rp_acitretin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_acitretin",
          "target": "n_adv_acitretin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_acitretin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致不良反应"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp_methotrexate",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_methotrexate",
          "target": "n_adv_methotrexate",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_methotrexate",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "drug_cyclosporine",
          "target": "n_ot_cyclosporine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致不良反应"
        },
        {
          "source": "n_ot_cyclosporine",
          "target": "n_rp_cyclosporine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_cyclosporine",
          "target": "n_adv_cyclosporine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_cyclosporine",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "drug_infliximab",
          "target": "n_ot_infliximab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致不良反应"
        },
        {
          "source": "n_ot_infliximab",
          "target": "n_rp_infliximab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_infliximab",
          "target": "n_adv_infliximab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_infliximab",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        }
      ],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "conflict_hotspots": [
            {
              "topic": "Acitretin不良反应风险",
              "pro_nodes": [
                "n_ot_acitretin"
              ],
              "con_nodes": [
                "n_adv_acitretin"
              ],
              "note": "潜在的离靶作用与不良反应之间的矛盾"
            }
          ]
        },
        "notes": "已完成 Acitretin 的安全性压力测试：标注高权重 refutes 边连到假设"
      },
      {
        "action_ref": 1,
        "status": "done",
        "graph_updates": {
          "conflict_hotspots": [
            {
              "topic": "Methotrexate不良反应风险",
              "pro_nodes": [
                "n_ot_methotrexate"
              ],
              "con_nodes": [
                "n_adv_methotrexate"
              ],
              "note": "潜在的离靶作用与不良反应之间的矛盾"
            }
          ]
        },
        "notes": "已完成 Methotrexate 的安全性压力测试：标注高权重 refutes 边连到假设"
      }
    ],
    "residual_conflicts": [
      "与药物特性相关的潜在离靶作用仍需进一步验证",
      "需评估各药物在特定人群（如老年人或有共病患者）中的安全性"
    ]
  }
}